Skip to main content
[Preprint]. 2023 Feb 1:2023.01.30.23285033. [Version 1] doi: 10.1101/2023.01.30.23285033

Table 1.

Crohn’s Disease Patients (n=4) UC Patients (n=9)
Sex 3 Male 9 Male
Race 4 Caucasian 9 Caucasian
Age at Diagnosis (Years) 12 (Range: 8-16) 19 (Range: 10-25)
Age at Enrollment (Years) 20 (Range: 18-23) 24 (Range: 14-29)
Disease Index
Mild 4 3
Mild/Moderate 0 3
Moderate 0 3
Concomitant Medications *
Amino-salicylates 1 4
Immunomodulators (6MP, MTX) 0 2
Anti-TNF Biologics 3 4
Other Biologics 2 0
Corticosteroids 1 5
Antibiotics 2 2
Baseline Fecal Calprotectin (μg/g) ** 1440 (Range: 1430-1450) 2190 (Range: 5-5730)
Normal: <50 N=2
Baseline CRP (mg/L) ** 2.45 (Range: 0.3-5.2) 1.9 (Range: 0.3-14.7)
Normal: 0-4.9 mg/L
Baseline ESR (mm/hr) ** 14.5 (Range: 2-41) 12 (Range: 2-79)
Normal: 0-32 mm/hr
Prior IBD-Related Hospitalization
Yes 2 6
No 0 1
Unknown 2 2
Arm Assigned
Treatment 2 6
Placebo 2 3
*

total > n because patients may be on multiple medications

**

Median values shown